Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis

Background: Recalcitrant neovascular age-related macular degeneration (rnAMD) despite intensive intravitreal anti-neovascular endothelial growth factor (VEGF) treatment, can be handled by switching to another anti-VEGF agent. This first systematic review and meta-analysis presents long-term data aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Hänsli, Christof, Schild, Christin, Pfister, Isabel, Garweg, Justus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051743/
https://www.ncbi.nlm.nih.gov/pubmed/36983970
http://dx.doi.org/10.3390/life13030814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051743/
https://www.ncbi.nlm.nih.gov/pubmed/36983970
http://dx.doi.org/10.3390/life13030814

Ejemplares similares